| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/18/2014 | US20140370080 Histone deacetylase (hdac) inhibitors for treatment of post-surgical adhesions |
| 12/18/2014 | US20140370079 Method for targeting vascular rhoj for inhibiting tumor angiogenesis |
| 12/18/2014 | US20140370012 Fusion proteins comprising igg2 hinge domains |
| 12/18/2014 | US20140370011 Methods of treating or preventing cognitive impairment using indane acetic acid derivatives |
| 12/18/2014 | US20140370010 Treatment of leukemias and chronic myeloproliferative diseases with antibodies to epha3 |
| 12/18/2014 | US20140370009 Therapeutic nanoparticles and methods of use thereof |
| 12/18/2014 | US20140370007 Method of directed differentiation producing corneal endothelial cells, compositions thereof, and uses thereof |
| 12/18/2014 | US20140370006 Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers |
| 12/18/2014 | US20140370005 Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers |
| 12/18/2014 | US20140370002 Methods for the treatment of gout |
| 12/18/2014 | US20140369997 Pharmaceutical composition for a foaming eye drop |
| 12/18/2014 | US20140369995 Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
| 12/18/2014 | US20140369990 Targeted antimicrobials and related compositions, methods and systems |
| 12/18/2014 | US20140369987 Dermaseptin b2 used as an inhibitor of the growth of a tumor |
| 12/18/2014 | US20140369982 Prebiotic and preservative uses of oil emulsified probiotic encapsulations |
| 12/18/2014 | US20140369977 Targeting Tumor Neovasculature with Modified Chimeric Antigen Receptors |
| 12/18/2014 | US20140369970 Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease |
| 12/18/2014 | US20140369963 Methods for the treatment of hepatitis b and hepatitis d infections |
| 12/18/2014 | US20140369962 Methods for the treatment of hepatitis b and hepatitis d infections |
| 12/18/2014 | US20140369961 Heterocyclic inhibitors of glutaminase |
| 12/18/2014 | US20140369959 4'-azido, 3'-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 12/18/2014 | US20140369930 Cyclotides as immunosuppressive agents |
| 12/18/2014 | US20140369926 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 12/17/2014 | CN104220062A (3s,3s'）4，4'-二硫烷二基双（3-氨基丁烷1-磺酸）和第二抗高血压药的组合 Combination (3s, 3s') 4,4'- disulfane diyl bis (3-amino-1- butane sulphonic acid) and a second anti-hypertensive drugs |
| 12/17/2014 | CN104208723A miR-638在抗急性髓系白血病中的应用 miR-638 application in anti-acute myeloid leukemia |
| 12/17/2014 | CN104208720A PPP3CC基因或其表达产物在治疗j11崎病中的应用 PPP3CC gene or its expression product in the treatment of Kawasaki disease in j11 |
| 12/17/2014 | CN104208708A 组合物在制备糖尿病患者用甜味剂和降糖产品中的应用 In the preparation of diabetics with sweeteners and hypoglycemic product application composition |
| 12/17/2014 | CN104208701A 含有抗真菌药物的复方吸入制剂 Compound preparations containing antifungal inhalation |
| 12/17/2014 | CN104208700A 含有抗细菌药物的复方吸入制剂 Compound contains anti-bacterial drug inhalation formulation |
| 12/17/2014 | CN104208699A 含有抗细菌药物的复方口服制剂 Combined oral formulations containing anti-bacterial drugs |
| 12/17/2014 | CN104208698A 一种经皮吸收镇痛消炎药物组合物及其应用 Percutaneous absorption of anti-inflammatory and analgesic pharmaceutical compositions and use |
| 12/17/2014 | CN104208697A 微生态制剂滴眼液 Probiotics Drops |
| 12/17/2014 | CN104208696A 组合物在制备改善骨质疏松产品中的应用 Composition in preparing improve osteoporosis product Application |
| 12/17/2014 | CN104208695A 一种多功能组合物及其制备方法与应用 A multifunctional composition and preparation method and application |
| 12/17/2014 | CN104208694A 组合物在制备改善睡眠产品中的应用 The composition in the preparation of the product in improving sleep Application |
| 12/17/2014 | CN104208693A 组合物在制备改善月经失调产品中的应用 Composition in preparing improved menstrual disorders product Application |
| 12/17/2014 | CN104208692A 组合物在制备通便清肠产品中的应用 Compositions in laxative bowel preparation products |
| 12/17/2014 | CN104208691A 组合物在制备减肥广品中的应用 The composition used in the preparation of a wide weight loss products in the |
| 12/17/2014 | CN104208690A 环索奈德、肾上腺素e2-受体激动剂分别包装并在一个吸入装置同时使用的药物组合物 Ciclesonide, e2- adrenergic receptor agonists and are packaged in a pharmaceutical composition for simultaneous use of the suction device |
| 12/17/2014 | CN104208689A 布地奈德、肾上腺素e2-受体激动剂分别包装并在一个吸入装置同时使用的药物组合物 Budesonide, e2- adrenergic receptor agonists and are packaged in a pharmaceutical composition for simultaneous use of the suction device |
| 12/17/2014 | CN104208688A 糠酸莫米松、肾上腺素e2-受体激动剂分别包装并在一个吸入装置同时使用的药物组合物 Mometasone furoate, e2- adrenergic receptor agonists and are packaged in a pharmaceutical composition for simultaneous use of the suction device |
| 12/17/2014 | CN104208687A 不同活性成分分别包装并在一个吸入装置同时使用的干粉吸入药物组合物 Different active ingredient packaged separately and simultaneously using a suction device of a dry powder inhaler pharmaceutical composition |
| 12/17/2014 | CN104208686A 氟替卡松、肾上腺素e2-受体激动剂分别包装并在一个吸入装置同时使用的药物组合物 Fluticasone, e2- adrenergic receptor agonists and are packaged in a suction device while using a pharmaceutical composition |
| 12/17/2014 | CN104208046A 一种碳青霉烯类抗生素的吸入制剂 A carbapenem antibiotic inhalation formulation |
| 12/17/2014 | CN104208045A 一种含有青霉素类抗生素、糖皮质激素的复方的吸入制剂 Containing penicillin antibiotics, corticosteroid inhaler formulation of compound |
| 12/17/2014 | CN104208014A 关节腔注射用温敏型原位凝胶及其制备方法 Intra-articular injection of temperature-sensitive in situ gel and its preparation method |
| 12/17/2014 | CN103157110B 芳香化酶抑制剂在制备抗肝硬化或抗肝纤维化的药物中的应用 Aromatase inhibitors used in the preparation of anti cirrhosis or hepatic fibrosis medicine |
| 12/17/2014 | CN102470118B 含有NSAIDs的外用剂及该外用剂的制造方法 The method of manufacturing the topical agent containing NSAIDs external preparation |
| 12/16/2014 | US8914089 Noninvasive measurement of chemical substances |
| 12/16/2014 | US8912359 Bisbenzamidines for the treatment of pneumonia |
| 12/16/2014 | US8912334 Biphenyl compounds useful as muscarinic receptor antagonists |
| 12/16/2014 | US8912331 3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases |
| 12/16/2014 | US8912329 Composition for treatment of tuberculosis |
| 12/16/2014 | US8912229 Taxane and abeo-taxane analogs |
| 12/16/2014 | US8912226 Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR |
| 12/16/2014 | US8912211 Medicinal compositions comprising buprenorphine and naltrexone |
| 12/16/2014 | US8912201 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders |
| 12/16/2014 | US8912200 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors |
| 12/16/2014 | US8912175 Topical compositions for treatment of skin conditions |
| 12/16/2014 | US8912171 Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis |
| 12/16/2014 | US8912169 Beta-lactamase inhibitors |
| 12/16/2014 | US8912167 Heparin-based compositions and methods for the inhibition of metastasis |
| 12/16/2014 | US8912164 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 12/16/2014 | US8912150 Ribosome structure and protein synthesis inhibitors |
| 12/16/2014 | US8912141 Treatment of hepatitis C virus |
| 12/16/2014 | US8912136 Methods and compositions related to clot-binding compounds |
| 12/16/2014 | US8911950 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 12/16/2014 | US8911936 MicroRNA fingerprints during human megakaryocytopoiesis |
| 12/16/2014 | US8911935 Mitochondria and human immunodefiency virus type 1 |
| 12/16/2014 | US8911791 Method for acne treatment using an oxidative-photoactivated composition |
| 12/16/2014 | US8911790 Solid composition containing a hypothiocyanite salt |
| 12/16/2014 | US8911786 Nanoparticle comprising rapamycin and albumin as anticancer agent |
| 12/16/2014 | US8911781 Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides |
| 12/16/2014 | US8911780 Multiparticulate L-menthol formulations and related methods |
| 12/16/2014 | US8911777 Pharmaceutical composition of tacrolimus |
| 12/16/2014 | US8911771 Fluid application device and method |
| 12/16/2014 | US8911770 Dissolvable dietary supplement strip and methods for using the same |
| 12/16/2014 | US8911749 Vaccine delivery via microneedle arrays |
| 12/16/2014 | US8911748 Cholera toxin chimera and its use as a staph vaccine |
| 12/16/2014 | US8911739 Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with Hsp60sp peptide |
| 12/16/2014 | US8911730 Methods of using antibodies to block human thymic stromal lymphopoietin (TSLP) receptor activity |
| 12/16/2014 | US8911724 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 12/16/2014 | US8911719 Tamper resistant dosage forms |
| 12/11/2014 | US20140364836 Pharmaceutical compositions for the treatment of inner ear disorders |
| 12/11/2014 | US20140364472 Pharmaceutical compositions comprising poh derivatives |
| 12/11/2014 | US20140364468 Method for treating obesity |
| 12/11/2014 | US20140364461 Method of treating dermatological disorders |
| 12/11/2014 | US20140364460 USE OF FATOSTATIN FOR TREATING CANCER HAVING A p53 MUTATION |
| 12/11/2014 | US20140364454 Metal-chelating compounds having at least one polyamino chain |
| 12/11/2014 | US20140364450 Aminopyridines useful as inhibitors of protein kinases |
| 12/11/2014 | US20140364447 Dual selective pi3 delta and gamma kinase inhibitors |
| 12/11/2014 | US20140364446 1',4'-thio nucleosides for the treatment of hcv |
| 12/11/2014 | US20140364442 Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds |
| 12/11/2014 | US20140364441 CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF |
| 12/11/2014 | US20140364438 Triazolopyridine derivatives as a tyrosine kinase inhibitor |
| 12/11/2014 | US20140364435 Amino-substituted imidazopyridazines |
| 12/11/2014 | US20140364429 Antiviral compounds highly effective as hcv-ns5a inhibitor |
| 12/11/2014 | US20140364424 Novel Sulfonaminoquinoline Hepcidin Antagonists |
| 12/11/2014 | US20140364416 COMPOSITIONS AND METHODS COMPRISING C16:1n7-PALMITOLEATE |
| 12/11/2014 | US20140364404 Articles and methods of treating vascular conditions |